Exploring a New Clinical Trial for KIT-Mutant GIST
Dr. Candace Haddox will discuss a new clinical trial combining ripretinib and navlimetostat for patients with KIT-mutant GIST and MTAP gene deletion, including eligibility and enrollment details.
Exploring The SARC044 Trial
Dr. Candace Haddox will present an overview of the Phase II SARC044 Clinical Trial.
Demystifying Clinical Trials
Dr. Candace Haddox of Dana-Farber Cancer Institute will offer invaluable insights into the world of clinical trials in honor of International Clinical Trials Awareness Day as well as discussing trials with GIST Advocate Kandee Evans